Supplement: Laureate Pharma: A Company on the Rise

Laureate Pharma: A Company on the Rise By Kathryn Ward Michiel Ultee ARTICLE EXTRAS A Region Defined A Robust Support Infrastructure The infrastructure ECRI Quest Pharmaceutical Immunicon Fox Chase Cancer Center Morgan, Lewis & Bockius Covance Coriell Paragon Chemical InstaMed In January 2007, Laureate Pharma announced record growth for 2006, with 14 new agreements signed and a business backlog increase of more than 240

Written byKathryn Ward
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A Region Defined

A Robust Support Infrastructure

The infrastructure

ECRI

Quest Pharmaceutical

Immunicon

Fox Chase Cancer Center

Morgan, Lewis & Bockius

Covance

Coriell

Paragon Chemical

InstaMed

In January 2007, Laureate Pharma announced record growth for 2006, with 14 new agreements signed and a business backlog increase of more than 240% over 2005. For the quarter ending June 30, 2007, it posted record-breaking results of a 178% increase in revenues over the same period in the previous year.

Based in Princeton, NJ, Laureate Pharma is a full-service outsource and contract manufacturing organization (CMO). The company helps biopharma companies speed new products from development through production by offering an array of services ranging from process design and development to full-scale production, testing, and regulatory support.

Michiel Ultee, senior director of processes science, says, "We don't have our own products. We're exclusively a contract manufacturer, and we work on our customers' products. Most ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies